Peripheral blood aspirates overexpressing IGF‐I via rAAV gene transfer undergo enhanced chondrogenic differentiation processes
Open Access
- 3 May 2017
- journal article
- research article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 21 (11) , 2748-2758
Abstract
Implantation of peripheral blood aspirates induced towards chondrogenic differentiation upon genetic modification in sites of articular cartilage injury may represent a powerful strategy to enhance cartilage repair. Such a single‐step approach may be less invasive than procedures based on the use of isolated or concentrated MSCs, simplifying translational protocols in patients. In this study, we provide evidence showing the feasibility of overexpressing the mitogenic and pro‐anabolic insulin‐like growth factor I (IGF‐I) in human peripheral blood aspirates via rAAV‐mediated gene transfer, leading to enhanced proliferative and chondrogenic differentiation (proteoglycans, type‐II collagen, SOX9) activities in the samples relative to control (reporter rAAV‐lacZ) treatment over extended periods of time (at least 21 days, the longest time‐point evaluated). Interestingly, IGF‐I gene transfer also triggered hypertrophic, osteo‐ and adipogenic differentiation processes in the aspirates, suggesting that careful regulation of IGF‐I expression may be necessary to contain these events in vivo. Still, the current results demonstrate the potential of targeting human peripheral blood aspirates via therapeutic rAAV transduction as a novel, convenient tool to treat articular cartilage injuries.Keywords
Funding Information
- German Osteoarthritis Foundation (Deutsche Arthrose-Hilfe e.V.)
This publication has 48 references indexed in Scilit:
- Arthroscopic Knee Cartilage Repair With Covered Microfracture and Bone Marrow ConcentrateArthroscopy Techniques, 2012
- SOX9 gene transfer via safe, stable, replication-defective recombinant adeno-associated virus vectors as a novel, powerful tool to enhance the chondrogenic potential of human mesenchymal stem cellsStem Cell Research & Therapy, 2012
- Co-delivery of SOX9 genes and anti-Cbfa-1 siRNA coated onto PLGA nanoparticles for chondrogenesis of human MSCsBiomaterials, 2012
- Metabolic Activities and Chondrogenic Differentiation of Human Mesenchymal Stem Cells Following Recombinant Adeno-Associated Virus–Mediated Gene Transfer and Overexpression of Fibroblast Growth Factor 2Tissue Engineering Part A, 2011
- Chondrogenic potential of blood-acquired mesenchymal progenitor cellsJournal of Plastic, Reconstructive & Aesthetic Surgery, 2010
- Insulin-like Growth Factor-I Induces Early Osteoblast Gene Expression in Human Mesenchymal Stem CellsStem Cells and Development, 2005
- The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilageArthritis & Rheumatism, 2004
- Response of the donor and recipient cells in mesenchymal cell transplantation to cartilage defectMicroscopy Research and Technique, 2002
- Treatment of Deep Cartilage Defects in the Knee with Autologous Chondrocyte TransplantationNew England Journal of Medicine, 1994
- Growth factor stimulation of adult articular cartilageJournal of Orthopaedic Research, 1989